Caribou Biosciences Inc (CRBU) — Financial Flexibility Index
Caribou Biosciences Inc (CRBU) has a Financial Flexibility Index of -0.36x as of December 2025. Free cash flow of $-20.61 Million (operating CF $-20.82 Million minus capex $216.00K) represents 0% of total liabilities ($57.46 Million). Also explore Caribou Biosciences Inc (CRBU) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Caribou Biosciences Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Caribou Biosciences Inc across 7 annual periods. Check CRBU strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Caribou Biosciences Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Caribou Biosciences Inc. For the full company profile including market capitalisation, see CRBU company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.06x | $-109.63 Million | $-110.99 Million | $53.19 Million | ▲ +5.5% |
| 2024 | -2.18x | $-131.69 Million | $-138.20 Million | $60.36 Million | ▼ -70.4% |
| 2023 | -1.28x | $-81.68 Million | $-93.29 Million | $63.81 Million | ▼ -10.4% |
| 2022 | -1.16x | $-84.51 Million | $-90.97 Million | $72.89 Million | ▼ -115.1% |
| 2021 | -0.54x | $-29.40 Million | $-32.52 Million | $54.53 Million | ▼ -0.5% |
| 2020 | -0.54x | $-31.90 Million | $-33.22 Million | $59.48 Million | ▲ +6.1% |
| 2019 | -0.57x | $-31.12 Million | $-32.01 Million | $54.47 Million | — |